UK govt backs DeepMind spinout’s $2.1bn plan to ‘solve all disease’ with AI ...
Genomics settles suit with rival and targets DNA sequencing startup ...
The risks that bite before, during and after closing ...
LSIPR's senior reporter Marisa Woutersen speaks with Mythili Markowski of Regeneron on why new USPTO guidance is putting post ...
21 April 2026 A New Jersey firm appoints the high-stakes litigator as chair of its trademarks, trade secrets and copyright ...
Panellists at INTA share how workplaces can bridge generational divides and why those differences may be a team’s biggest strengths.
LSIPR's senior reporter Marisa Woutersen speaks with Ben Doranz of Integral Molecular, fresh from the stage at LSPN Boston ...
John Ward, vice president and associate general counsel of trademarks at Moderna, reveals what it means to be an AI-first ...
J&J’s Abiomed can proceed with its non-infringement defence despite potential future appellate reversal, in a week when both ...
As the world moves past the pandemic, a massive legal struggle over the future of mRNA technology is just hitting its stride. LSIPR visualises the litigation defining the next era.
Patent litigator and attorney swaps the capital of Massachusetts for Los Angeles and San Francisco, bringing a broad patent practice across tech and life sciences.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results